Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
5.27
-0.22 (-4.01%)
Apr 29, 2026, 10:27 AM EDT - Market open
Atossa Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 41.3 | 71.08 | 88.46 | 110.89 | 136.38 | Upgrade
|
| Cash & Short-Term Investments | 41.3 | 71.08 | 88.46 | 110.89 | 136.38 | Upgrade
|
| Cash Growth | -41.90% | -19.64% | -20.23% | -18.69% | 244.79% | Upgrade
|
| Other Receivables | - | - | - | 0.74 | 1.07 | Upgrade
|
| Receivables | - | - | - | 0.74 | 1.07 | Upgrade
|
| Inventory | 3.08 | 2.1 | 1.49 | 5.25 | - | Upgrade
|
| Prepaid Expenses | 0.59 | 0.7 | 1.3 | 1.21 | 2.49 | Upgrade
|
| Restricted Cash | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | Upgrade
|
| Other Current Assets | 0.54 | 0.47 | 0.87 | - | 1.19 | Upgrade
|
| Total Current Assets | 45.62 | 74.46 | 92.22 | 118.2 | 141.24 | Upgrade
|
| Long-Term Investments | - | - | 1.71 | 4.7 | - | Upgrade
|
| Other Long-Term Assets | 1.99 | 1.99 | 2.32 | 0.64 | 0.02 | Upgrade
|
| Total Assets | 47.61 | 76.44 | 96.25 | 123.53 | 141.26 | Upgrade
|
| Accounts Payable | 4.29 | 0.68 | 0.81 | 2.97 | 1.72 | Upgrade
|
| Accrued Expenses | 2.87 | 2.78 | 2.63 | 2.58 | 1.39 | Upgrade
|
| Other Current Liabilities | 1.1 | 1.51 | 1.8 | 0.02 | 0.02 | Upgrade
|
| Total Current Liabilities | 8.26 | 4.97 | 5.24 | 5.57 | 3.13 | Upgrade
|
| Total Liabilities | 8.26 | 4.97 | 5.24 | 5.57 | 3.13 | Upgrade
|
| Common Stock | 1.55 | 1.55 | 22.79 | 22.79 | 22.79 | Upgrade
|
| Additional Paid-In Capital | 285.84 | 283.19 | 255.99 | 251.37 | 244 | Upgrade
|
| Retained Earnings | -246.56 | -211.79 | -186.29 | -156.19 | -129.23 | Upgrade
|
| Treasury Stock | -1.48 | -1.48 | -1.48 | - | - | Upgrade
|
| Total Common Equity | 39.35 | 71.48 | 91.02 | 117.96 | 137.55 | Upgrade
|
| Shareholders' Equity | 39.35 | 71.48 | 91.02 | 117.96 | 138.14 | Upgrade
|
| Total Liabilities & Equity | 47.61 | 76.44 | 96.25 | 123.53 | 141.26 | Upgrade
|
| Net Cash (Debt) | 41.3 | 71.08 | 88.46 | 110.89 | 136.38 | Upgrade
|
| Net Cash Growth | -41.90% | -19.64% | -20.23% | -18.69% | 244.94% | Upgrade
|
| Net Cash Per Share | 4.80 | 8.47 | 10.52 | 13.14 | 17.49 | Upgrade
|
| Filing Date Shares Outstanding | 8.61 | 8.61 | 8.35 | 8.44 | 8.44 | Upgrade
|
| Total Common Shares Outstanding | 8.61 | 8.61 | 8.35 | 8.44 | 8.44 | Upgrade
|
| Working Capital | 37.36 | 69.49 | 86.98 | 112.63 | 138.11 | Upgrade
|
| Book Value Per Share | 4.57 | 8.30 | 10.90 | 13.97 | 16.29 | Upgrade
|
| Tangible Book Value | 39.35 | 71.48 | 91.02 | 117.96 | 137.55 | Upgrade
|
| Tangible Book Value Per Share | 4.57 | 8.30 | 10.90 | 13.97 | 16.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.